Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 147.96 million compared to CNY 95.77 million a year ago. Revenue was CNY 147.96 million compared to CNY 95.77 million a year ago. Net income was CNY 33.4 million compared to CNY 20.53 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 0.34 a year ago. Diluted earnings per share from continuing operations was CNY 0.42 compared to CNY 0.34 a year ago.